Track Kimia Biosciences Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -6.26 %
Low
28.1
High
32.5
1 Month returns: -3.98 %
Low
28.1
High
35.0
1 Year returns: -35.37 %
Low
23.2
High
46.3
3 Year CAGR: -5.70 %
Low
23.2
High
86.8
5 Year CAGR: -10.27 %
Low
23.2
High
86.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Kimia Biosciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Kimia Biosciences Ltd. Shareholding Pattern
Quarterly breakdown of Kimia Biosciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Kimia Biosciences Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Kimia Biosciences Ltd.?
The current share price of Kimia Biosciences Ltd. is ₹ 29.93 as of 7 Aug 2026.
What is the market capitalisation of Kimia Biosciences Ltd.?
The market capitalisation of Kimia Biosciences Ltd. stands at ₹ 141.61 Cr.
What is the PE ratio of Kimia Biosciences Ltd.?
The Price-to-Earnings (PE) ratio of Kimia Biosciences Ltd. is 19.05 as of the latest trailing twelve months data.
What is the ROE and ROCE of Kimia Biosciences Ltd.?
Kimia Biosciences Ltd. has a Return on Equity (ROE) of 53.70% and a Return on Capital Employed (ROCE) of 20.34% as per the latest financial reports.
What is the 52-week high and low of Kimia Biosciences Ltd.?
The 52-week high of Kimia Biosciences Ltd. is - and the 52-week low is -.
What is the dividend yield of Kimia Biosciences Ltd.?
The dividend yield of Kimia Biosciences Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Kimia Biosciences Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.38% and retail/public investors hold 24.45% of Kimia Biosciences Ltd. shares.
What sector does Kimia Biosciences Ltd. belong to?
Kimia Biosciences Ltd. operates in the Healthcare sector.
What is the beta of Kimia Biosciences Ltd.?
The beta of Kimia Biosciences Ltd. is 1.14, indicating its price volatility relative to the broader market. Over the past 1 year, Kimia Biosciences Ltd. has delivered an absolute return of -51.72%.
What is the RSI of Kimia Biosciences Ltd.?
The 14-day Relative Strength Index (RSI) of Kimia Biosciences Ltd. is 37.65, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Kimia Biosciences Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
PE TTM of 19.05 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -37.72%
What is P/E Ratio?
Median: 30.59
Value 19.05
0.33286.35
Negative
Weak price momentum
Price Momentum score of 14.5 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
14.5 / 100
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 51.9 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
51.9 / 100
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0125495.
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Promoter
74.42
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
Indian Promoter
74.42
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
74.94
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
0.39
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
Mutual Funds / UTI
0.39
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
0.38
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
25.19
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
24.68
Bodies Corporate
0.33
0.30
0.29
0.28
0.28
0.28
0.28
0.28
0.27
0.27
0.25
0.24
0.24
0.25
0.25
0.24
0.23
0.22
0.23
0.24
0.22
0.24
0.25
0.23
0.23
0.23
Others (incl. Retail)
No. of shareholders
24.86
11,650
24.38
11,656
24.39
11,822
24.40
11,776
24.40
11,858
24.40
12,139
24.40
12,120
24.40
12,159
24.41
12,459
24.41
12,404
24.43
12,343
24.44
12,195
24.44
12,153
24.43
12,098
24.43
12,069
24.44
12,014
24.45
12,065
24.46
11,977
24.45
12,132
24.44
12,184
24.46
12,231
24.44
12,150
24.43
12,568
24.45
12,705
24.45
12,729
24.45
12,729
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
No bulk, block or insider trade data available.
Corporate Actions
History of Kimia Biosciences Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Others
Ex-date: 15th Nov 2018Announced on: 3rd Nov 2018
Nominal value change from INR 10 to INR 1.
Company Profile
Overview of Kimia Biosciences Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Kimia Biosciences Limited is an India-based company, which is engaged in the manufacturing of bulk drugs addressing various high-potential therapeutic segments. The Company provides its products under various categories: Commercial Active Pharmaceutical Ingredients (APIs), and Commercial KSMs, Intermediates and Reagents. The Companys Commercial-APIs products include Acotiamide Hydrochloride Hydrate, Azelnidipine, Benfotiamine, Benidipine Hydrochloride, Citicoline Sodium, Gliclazide, Dapagliflozin Propanediol Monohydrate, Levosulpiride, Luliconazole, Oxaceprol, Prucalopride Succinate, Teneligliptin Hydrobromide Hydrate, Vildagliptin, Fimasartan Trihydrate Potassium, Obeticholic Acid, Ursodeoxycholic Acid and others. Its Commercial KSMs, Intermediates and Reagents products include Ethyl-2-Amino 1,3-Thiazole 4-Carboxylate; 2,4,5-Trimethoxy Benzoic Acid; Ethyl 2-(2,4,5-trimethoxybenzamido)-1,3-thiazole-4-carboxylate; Choline phosphate chloride calcium, and others.
Kimia Biosciences Limited is an India-based company, which is engaged in the manufacturing of bulk drugs addressing various high-potential therapeutic segments. The Company provides its products under various categories: Commercial Active Pharmaceutical Ingredients (APIs), and Commercial KSMs, Inter...
Key personnel
Mr. Abhishek Kumar Pandey
Compliance Officer, Company Secretary
Mr. Sameer GoelD
Executive Chairman of the Board, Chief Executive Officer, Managing Director
Mr. Ramakrishnavara Prasada Raju MantenaD
Director - Technical Director
Mr. Amulya Kumar NayakD
Additional Non-Executive Non-Independent Director
Ms. Reema GoyalD
Additional Non-Executive Independent Woman Director